Trademark: 88797477
Status Date
Monday, August 7, 2023
Filing Date
Friday, February 14, 2020
Published for Opposition
Tuesday, January 12, 2021
Abandoned Date
Monday, August 7, 2023
9 Biotechnological products, namely, bio-chips for scientific purposes
5 Biotechnological products, namely, diagnostic reagents, medicines for gene therapy for the treatment of genetic diseases and/or cancer for medical purposes; Medicines for treating genetic disorders; Nanoparticles carrying drugs and nucleic acids for treating cancers; Synthetic peptide based nanoparticles for gene therapy for the treatment of genetic diseases and/or cancer; protein-based nanoparticles for gene therapy for the treatment of genetic diseases and/or cancer; cell-based therapeutic products, namely, vaccines; Pharmaceutical compounds for gene therapy for the treatment of genetic diseases and/or cancer; Biological material, namely, biological diagnostic preparations for gene therapy for the treatment of genetic diseases and/or cancer; Nucleic acids for medical purposes; proteins arrays for medical diagnosis purposes; cells for medical use; self-replicating nucleic acids for medical purposes; peptides for gene therapy for the treatment of genetic diseases and/or cancer; Eukaryotic cells for medical purposes; Prokaryotic cells for medical purposes; Stem cells for medical purposes; Living cells for medical purposes; Pharmaceutical compounds for gene therapy for the treatment of genetic diseases and/or cancer, vaccines, diagnostic rubbing compounds for medical purposes; Delivery vehicles, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; Reagents for medical purposes; Diagnostic reagents for medicinal use; Bacteria for medical purposes; Diagnostic bacteria for medicinal use; Biochemical compounds for gene therapy for the treatment of genetic diseases and/or cancer for medical and veterinary application; Vaccines for medical and veterinary use
1 Biotechnological products, namely, chemicals for use in biotechnological product development for scientific purposes; Biological material, namely, biochemical preparations for scientific purposes; Cells for scientific purposes; Eukaryotic cells for scientific purposes; Prokaryotic cells for scientific purposes; Stem cells for scientific purposes; Living cells for scientific purposes; Reagents for scientific purposes; Diagnostic reagents for scientific use; Bacteria for scientific purposes; Diagnostic biomedical compounds, namely, peptide substrates used in analyzing and detecting certain toxins for scientific purposes; Nucleic acid for laboratory use; Proteins for use in manufacture; Small molecules being chemical compounds for use in patterning at nano scale or near nano scale
42 Consultancy in the field of biotechnology; Research and development in the field of biotechnology; Research and development in the field of immunology; Research and development in the field of biochemistry
Aug 7, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 7, 2023
Abandonment - No Use Statement Filed
Dec 8, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 6, 2022
Sou Extension 3 Granted
Dec 6, 2022
Sou Extension 3 Filed
Dec 6, 2022
Teas Extension Received
Jun 28, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 24, 2022
Sou Extension 2 Granted
Jun 24, 2022
Sou Extension 2 Filed
Jun 24, 2022
Teas Extension Received
Dec 1, 2021
Notice Of Approval Of Extension Request E-Mailed
Nov 29, 2021
Sou Extension 1 Granted
Nov 29, 2021
Sou Extension 1 Filed
Nov 29, 2021
Teas Extension Received
Jul 6, 2021
Noa E-Mailed - Sou Required From Applicant
May 23, 2021
Extension Of Time To Oppose Process - Terminated
Feb 10, 2021
Extension Of Time To Oppose Received
Jan 12, 2021
Official Gazette Publication Confirmation E-Mailed
Jan 12, 2021
Published For Opposition
Dec 23, 2020
Notification Of Notice Of Publication E-Mailed
Dec 4, 2020
Approved For Pub - Principal Register
Dec 2, 2020
Examiner's Amendment Entered
Dec 2, 2020
Notification Of Examiners Amendment E-Mailed
Dec 2, 2020
Examiners Amendment E-Mailed
Dec 2, 2020
Examiners Amendment -Written
Nov 10, 2020
Teas/Email Correspondence Entered
Nov 9, 2020
Correspondence Received In Law Office
Nov 9, 2020
Teas Response To Office Action Received
Jul 27, 2020
Assigned To Examiner
May 15, 2020
Notification Of Non-Final Action E-Mailed
May 15, 2020
Non-Final Action E-Mailed
May 15, 2020
Non-Final Action Written
May 6, 2020
Assigned To Examiner
Feb 20, 2020
New Application Office Supplied Data Entered
Feb 18, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
